Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.

Condition:   NAFLD Cirrhosis Interventions:   Drug: Dapagliflozin;   Other: Standard of Care Sponsor:   Institute of Liver and Biliary Sciences, India Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials